- Home
- WHLR vs OGEN Comparison
WHLR vs OGEN Comparison
Compare WHLR & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHLR
- OGEN
- Stock Information
- Founded
- WHLR 2011
- OGEN 1996
- Country
- WHLR United States
- OGEN United States
- Employees
- WHLR N/A
- OGEN 5
- Industry
- WHLR Real Estate Investment Trusts
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- WHLR Real Estate
- OGEN Health Care
- Exchange
- WHLR Nasdaq
- OGEN Nasdaq
- Market Cap
- WHLR 4.2M
- OGEN 5.4M
- IPO Year
- WHLR 2012
- OGEN N/A
- Fundamental
- Price
- WHLR $4.90
- OGEN $1.33
- Analyst Decision
- WHLR
- OGEN
- Analyst Count
- WHLR 0
- OGEN 0
- Target Price
- WHLR N/A
- OGEN N/A
- AVG Volume (30 Days)
- WHLR 719.6K
- OGEN 240.0K
- Earning Date
- WHLR 11-06-2025
- OGEN 11-12-2025
- Dividend Yield
- WHLR N/A
- OGEN N/A
- EPS Growth
- WHLR N/A
- OGEN N/A
- EPS
- WHLR N/A
- OGEN N/A
- Revenue
- WHLR $102,799,000.00
- OGEN N/A
- Revenue This Year
- WHLR N/A
- OGEN N/A
- Revenue Next Year
- WHLR N/A
- OGEN N/A
- P/E Ratio
- WHLR N/A
- OGEN N/A
- Revenue Growth
- WHLR N/A
- OGEN N/A
- 52 Week Low
- WHLR $4.74
- OGEN $1.01
- 52 Week High
- WHLR $22,400.00
- OGEN $18.90
- Technical
- Relative Strength Index (RSI)
- WHLR 53.21
- OGEN 51.39
- Support Level
- WHLR $5.35
- OGEN $1.24
- Resistance Level
- WHLR $6.13
- OGEN $1.43
- Average True Range (ATR)
- WHLR 0.53
- OGEN 0.10
- MACD
- WHLR -0.03
- OGEN 0.01
- Stochastic Oscillator
- WHLR 58.15
- OGEN 57.86
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.